Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
National Institute of Allergy and Infectious Diseases (NIAID)
Shahin Lockman; Sean S Brummel; Lauren Ziemba; Lynda Stranix-Chibanda; Katie McCarthy; Anne Coletti; Patrick Jean-Philippe; Ben Johnston; Chelsea Krotje; Lee Fairlie; Risa M Hoffman; Paul E Sax; Sikhulile Moyo; Nahida Chakhtoura; Jeffrey Sa Stringer; Gaerolwe Masheto; Violet Korutaro; Haseena Cassim; Blandina T Mmbaga; Esau João; Sherika Hanley; Lynette Purdue; Lewis B Holmes; Jeremiah D Momper; Roger L Shapiro; Navdeep K Thoofer; James F Rooney; Lisa M Frenkel; K Rivet Amico; Lameck Chinula; Judith Currier; IMPAACT 2010/VESTED Study Team and Investigators
Center for Biostatistics in AIDS Research, Harvard TH Chan School of Public Health, Boston, MA, USA. ; Center for Biostatistics in AIDS Research, Harvard TH Chan School of Public Health, Boston, MA, USA.